NNNN ANBIO BIOTECHNOLOGY
FollowSHS CL A (common), issuer CIK 1982708
6 managers (6 13F filers) reported a position in NNNN shares at 2025-06-30, 29,586 shares in all. 3 filers opened a position and 1 filer sold out during the quarter.
- Managers
- 6
- 13F filers
- 6
- New
- 3
- Added
- 2
- Reduced
- 0
- Sold out
- 1
- Shares held by filers
- 29,586
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q2 2025
Filers in the available 13F reports with a share position at 2025-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLCin group GEODE CAPITAL MANAGEMENT, LLC | 17,130 | $542K | <0.01% | +70 | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 10,695 | $339K | <0.01% | +4,957 | 13F-HRTimelineGroup |
| BNP PARIBAS FINANCIAL MARKETSin group BNP PARIBAS FINANCIAL MARKETS | 1,261 | $39.9K | <0.01% | new | 13F-HRTimelineGroup |
| MORGAN STANLEYin group MORGAN STANLEY | 400 | $12.7K | <0.01% | new | 13F-HRTimelineGroup |
| WELLS FARGO & COMPANY/MNin group WELLS FARGO & COMPANY/MN | 100 | $3.17K | <0.01% | new | 13F-HRTimelineGroup |
| CONCOURSE FINANCIAL GROUP SECURITIES, I… | 0 | $0 | 0 | 13F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios. |